© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
February 09, 2021
Migraine attacks are the leading cause of disability in individuals younger than 50 years and predominantly affect women.
February 05, 2021
The diagnosis and management of neurologic conditions can be more complex when patients are at the extremes of age.
February 01, 2021
The new administration option for multiple sclerosis treatment could improve access during the COVID-19 pandemic, when availability has been a concern.
January 29, 2021
As care improves, cognitive impairment is likely to be seen earlier in patients with coronary artery disease, diabetes, and HIV.
January 27, 2021
Because there are multiple sources for concussion-like symptoms, student-athletes’ post-concussion care should zero in on which symptoms are specifically caused by the injury and which may be caused by other issues.
January 26, 2021
Studies have shown that patients with Parkinson disease admitted to the hospital experience longer hospital stays and increased mortality than age matched control groups.
January 25, 2021
Amantadine, a treatment that was originally used as an agent against influenza A, lost efficacy due to viral resistance.
The approach is being developed specifically as a potential treatment for the significant fraction of people with debilitating depression who do not respond to existing therapies and are at high risk of suicide.
January 20, 2021
The increased risk may be due to changes in the brain’s dopamine system caused by dopamine receptor antagonists or neurobiological effects of schizophrenia.
January 15, 2021
The symptoms of depression in caregivers of patients with dementia exacerbates over time.